Loading...
XSHE000813
Market cap871mUSD
Jan 13, Last price  
2.95CNY
1D
-0.67%
1Q
7.27%
Jan 2017
-69.33%
Name

Dezhan Healthcare Co Ltd

Chart & Performance

D1W1MN
XSHE:000813 chart
P/E
76.66
P/S
12.82
EPS
0.04
Div Yield, %
0.00%
Shrs. gr., 5y
-0.49%
Rev. gr., 5y
-31.45%
Revenues
498m
-12.75%
338,626,811358,075,854310,956,678338,080,796381,218,752248,879,079296,633,730300,757,145257,304,950569,175,768559,371,797510,772,7491,442,998,6252,220,294,8183,290,827,5921,774,968,109962,867,939734,479,885570,855,435498,088,171
Net income
83m
09,895,75712,665,54115,546,8512,198,75106,322,7833,471,827026,256,52321,503,6366,159,630661,671,880797,177,693930,525,670336,921,030284,544,4080083,314,246
CFO
128m
-20.93%
44,727,392134,831,22922,624,834056,526,56236,027,0870016,510,559170,585,210136,465,461124,913,816262,356,181384,636,714379,780,8701,558,808,735827,536,28842,409,946161,719,681127,872,780
Dividend
Jun 01, 20210.21 CNY/sh
Earnings
May 08, 2025

Profile

Dezhan Healthcare Company Limited researches and develops, manufactures, and sells cardiovascular and cerebrovascular drugs in China. It also offers anti-cancer drugs, health care products, functional beverages, and ecological water. The company was founded in 1998 and is based in Urumqi, China.
URL
http://www.dezhanhealthcare.com/
IPO date
May 19, 1998
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
498,088
-12.75%
570,855
-22.28%
Cost of revenue
400,300
496,260
Unusual Expense (Income)
NOPBT
97,788
74,596
NOPBT Margin
19.63%
13.07%
Operating Taxes
27,599
32,335
Tax Rate
28.22%
43.35%
NOPAT
70,189
42,261
Net income
83,314
 
Dividends
(29)
Dividend yield
0.00%
Proceeds from repurchase of equity
(147,185)
(11,828)
BB yield
2.06%
0.14%
Debt
Debt current
868
2,173
Long-term debt
9,270
13,800
Deferred revenue
7,648
9,339
Other long-term liabilities
5,000
21,179
Net debt
(3,320,973)
(3,131,391)
Cash flow
Cash from operating activities
127,873
161,720
CAPEX
(159,732)
Cash from investing activities
178,022
1,009,000
Cash from financing activities
(160,110)
FCF
366,475
440,577
Balance
Cash
2,796,417
2,599,135
Long term investments
534,694
548,229
Excess cash
3,306,207
3,118,822
Stockholders' equity
4,804,579
4,778,388
Invested Capital
1,953,412
2,196,813
ROIC
3.38%
1.48%
ROCE
1.85%
1.40%
EV
Common stock shares outstanding
2,181,001
2,226,394
Price
3.27
-11.86%
3.71
-8.85%
Market cap
7,131,874
-13.66%
8,259,923
-9.38%
EV
3,814,465
5,128,532
EBITDA
186,653
169,258
EV/EBITDA
20.44
30.30
Interest
1,172
712
Interest/NOPBT
1.20%
0.95%